Will a Glaucoma Drug Revolutionize Androgenetic Alopecia Treatment? On Repurposing a Drug Whose Side Effect Became a Desired Therapy Outcome.

    November 2024 in “ Postępy Biochemii ”
    Kalina Spławska, Łukasz Zybaczyński, Maciej Wierzbicki, Katarzyna Koziak
    Studysummary This article highlights the potential for latanoprost acid, a metabolite of the glaucoma medication latanoprost, to serve as an effective alternative to current treatments for androgenetic alopecia, such as minoxidil and finasteride, facilitating a faster development process for related drugs.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on postepybiochemii.ptbioch.edu.pl →
    Discuss this study in the Community →